CME webinar: Heart Failure Success: Teaching the Teachers (recorded)

Aug. 2024Education/Webinars

Please make time to review this on-demand, continuing medical education (CME)-accredited webinar on heart failure. During this presentation, Jennifer Kliner, CRNP:

  • Defined the updated classifications and definitions of heart failure.*
  • Reviewed guideline-directed medical therapies (GDMT) and practical components of initiating and maintaining GDMT.
  • Outlined symptoms, side effects, and when a provider should be called.
  • Detailed suggested lifestyle modifications, such as those for dietary and/or fluid restrictions and activity.

*Per the 2022 AHA/ACC/HFSA Guidelines for Management of Heart Failure

Presenter:
Jennifer Kliner, CRNP
Supervisor, UPMC Heart and Vascular Institute, Advanced Heart Failure and Pulmonary Hypertension Program; Regional Director, Heart Failure Medication Optimization Clinics; Program Coordinator, Comprehensive Pulmonary Hypertension

Watch now.

You may earn continuing medical education (CME) credits for attending this webinar. This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

This activity has been designated as and meets the Pennsylvania licensure requirement for Patient Safety-Risk Management Credit. It is the responsibility of the learner to maintain the educational presentation or conference agenda as evidence, if needed for audit purposes.

Provider is responsible for verifying CME eligibility.


Recent Announcements

CME webinar series: Empowering Providers on Substance Use Disorders

Register for our new CME webinar series: Empowering Providers on Substance Use Disorders
Jun. 2025Education/Webinars

CME webinar series: Empowering Providers on Substance Use Disorders

Register for our new CME webinar series: Empowering Providers on Substance Use Disorders
Jun. 2025Education/Webinars

Voluntary nationwide recall: Sulfamethoxazole/Trimethoprim (Amneal – June)

Amneal Pharmaceutical LLC is recalling certain lots of Sulfamethoxazole/Trimethoprim Tablets, USP, 400 mg/80 mg. Sulfamethoxazole/Trimethoprim is used for the treatment of certain bacterial infections.
Jun. 2025Pharmacy Updates